0.5065USD+0.90%Mkt Cap: 17.71M USDP/E: 16.82Last update: 2026-05-26
OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Germany, Switzerland, and South Korea. The company develops immunotherapy products, inclu…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap17.71M USD
Enterprise Value44.83M USD
Revenue (TTM)2.63M USD
Gross Profit592.90K USD
Net Income (TTM)-18.01M USD
Revenue/Share0.1050 USD
Last Price0.5065 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees22
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)16.82
P/E (Forward)—
PEG—
EV/EBITDA-4.66
EV/Revenue17.05
P/S6.81
P/B0.17
EPS (TTM)0.03
EPS (Forward)—
52W Range
0.38009% of range1.790
52W High1.790 USD
52W Low0.3800 USD
Profitability
Gross Margin20.40%
Oper. Margin-757.59%
EBITDA Margin0.00%
Profit Margin-619.82%
ROE-23.20%
ROA-10.52%
Growth
Revenue Growth-36.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.33M USD
CapEx (TTM)176.38K USD
FCF Margin52.66%
FCF Yield7.81%
Net Debt3.39M USD
Net Debt/EBITDA-0.35
Balance Sheet
Debt/Equity0.06
Current Ratio0.16
Quick Ratio0.10
Book Value/Sh2.919 USD
Cash/Share0.0450 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)10.00 USD
Target Range10.00 USD – 10.00 USD
# Analysts1
Ownership
Shares Out.35.10M
Float13.43M
Insiders45.84%
Institutions0.83%
Short Interest
Short Ratio0.1d
Short % Float10.84%
Short % Out.3.87%
Shares Short1.28M
Short (prev mo.)916.51K
Technical
SMA 500.5465 (-7.3%)
SMA 2000.5913 (-14.3%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)12.17M
Avg Vol (10d)1.54M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—